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Repeated exposure to hair dye  
induces regulatory T cells in mice
Rubin et al. studied how exposure to p-phenylenediamine 
(PPD)-containing hair dye, in a consumer-like fashion, 
affected pro- and anti-inflammatory immune responses 
in a mouse model. The inflammatory response peaked 
at the fourth exposure to hair dye after which there was 
an up-regulation of regulatory T cells and IL-10 produc-
ing cells. In addition to being potent skin sensitizers 
that activate inflammatory T cells, hair dyes also induce 
anti-inflammatory mechanisms. This might explain why 
many consumers can use hair dyes repeatedly without 
developing overt allergies, but also raises the question 
whether the immune modulatory effects of hair dyes might 
influence the development of autoimmune diseases and 
cancers. Br J Dermatol 2010; 163: 992–98.
Long-term follow-up study  
of occupational hand eczema
Mälkönen et al. report the prognostic risk factors for the 
continuation of occupational hand eczema (OHE) in 605 
patients after a follow-up of 7-14 years. The hand eczema 
had healed (no eczema during the last year) in 40% of 
OHE patients. In the logistic model, risk factors for the 
continuation of OHE were the long duration of hand 
eczema before diagnosis, respiratory atopy, skin atopy, 
and continuation in the same occupation. Since the 
majority of signs for poor long-term prognosis are detect-
able in the early stages, the importance of early diagnosis 
and intervention is emphasised. Br J Dermatol 2010; 163: 
999–1006.
Hair removal in hirsute women  
with normal testosterone levels:  
a randomized controlled trial of long-pulsed 
diode laser vs. intense pulsed light
Haak et al. compared the efficacy and safety of intense 
pulsed light (IPL) vs. long-pulsed diode laser (LPDL) in a 
group of hirsute women with intrinsically normal or med-
ically normalized testosterone levels. Thirty-one women 
received six allocated split-face treatments with IPL and 
LPDL. Patients responded equally well and obtained sig-
nificant hair removal efficacies from IPL and LPDL treat-
ments with 77% to 40% hair reduction for IPL and 68% to 
34% for LPDL during the 1–6-month follow-up period. At 
6 months follow-up, there was no significant difference 
between treatments in terms of hair reduction (P = 0.427), 
patient assessment of hairiness (P = 0.250) and patient sat-
isfaction (P = 0.125). Pain scores were consistently higher 
for IPL than LPDL. Br J Dermatol 2010; 163: 1007–13.
The role of sunlight exposure  
in determining the vitamin D status  
of the U.K. white adult population 
Webb et al. performed a single-centre, prospective cohort 
study to examine whether personal sunlight exposure 
levels can provide vitamin D sufficient (≥ 20 ng mL–1) 
status in the U.K. A late summer peak of around 32 ng 
mL–1 is required in order to remain vitamin D sufficient 
year round. Currently the majority of the U.K. population 
fails to reach this post-summer level and becomes vitamin 
D insufficient during the winter. It is proposed that opti-
mal vitamin D status might be better considered as an end 
of summer rather than a year-round goal. Br J Dermatol 
2010; 163: 1050–55.
Activating BRAF Mutations  
in Eruptive Melanocytic Nevi
Sekulic et al. evaluated whether activating BRAF muta-
tions may play a role in the genesis of eruptive melanocyt-
ic nevi (EMN). Genomic DNA was isolated from 20 EMN 
from a 6-mercaptopurine (6-MP) treated patient. The BRAF 
V600E mutation was identified in 85% of examined EMN. 
Results implicate mutational activation of BRAF-MAPK 
pathway as a factor in development of EMN in the setting 
of 6-MP treatment. The mechanism leading to develop-
ment of EMN in this, and potentially other patients, may 
relate to synergistic mutagenic effects of thioguanines and 
UVA. Together with the documented importance of BRAF 
mutations in melanoma development and maintenance, 
these findings highlight the importance of UVA protec-
tion, especially in the setting of thiopurine treatment. Br J 
Dermatol 2010; 163: 1095–98.
